Wockhardt logo

Wockhardt share news and announcements

NSE: WOCKPHARMABSE: 532300Pharmaceuticals & BiotechnologySmall Cap

Last close ₹1,801.70down ₹53.80 (2.90%)BSE ₹1,801.25

Share price at the NSE close on 23 Oct 2026. Previous close ₹1,855.50.

52-week range of traded prices to 23 Oct 2026
₹1,086.70Low, 23 Mar 2026₹2,422.30High, 1 Jun 2026
Market cap
₹29,276 Cr311th largest listed
P/E
71.6
P/B
5.9
Dividend yield
Nonein the last 12 months
ROE
8.8%
ROCE
7.4%
Debt to equity
0.40
Volume, NSE
8,79,19043.6% delivered

Wockhardt share news and announcements

1,008 announcements, routine notices left out, newest first. Page 14 of 21.

  1. Nov 2014

  2. Oct 2014

  3. Sep 2014

  4. Aug 2014

  5. Jul 2014

  6. Jun 2014

  7. May 2014

    • 28 May · Legal

      Exchange had sought clarification from Wockhardt Limited with respect to news item captioned "USFDA raises concern over Wockhardt plant". The Company has clarified that "Inspection of plants by regulatory authorities such as US FDA are done in normal course of business and post inspection the authorities provide their observation to the Company on a form called FDA Form 483 . The Company is required to provide its response addressing each observation, based on which the authorities decide the further course of action. The Company s subsidiary Morton Grove Pharmaceuticals Ltd, based out of USA and having a manufacturing plant in Chicago has received FDA Form 483 . Kindly note that issuance of observations per se does not result in any material impact".
    • 26 May · Dividend

      Board of Directors of the Company at its meeting held on May 26, 2014 recommended dividend @ 0.01% (Rs. 0.0005 per preference share of Rs. 5/- each) absorbing a sum of Rs. 298,557/- on 475,659,941 Non-Convertible Cumulative Redeemable Preference shares of Rs. 5/- each and 121,454,927 Optionally Convertible Cumulative Redeemable Preference Shares of Rs. 5/- each. The dividend, if declared at the Annual General Meeting, will be paid within 30 days from the date of Annual General Meeting.
    • 26 May · Board meeting

      Board of Directors at its meeting held on May 26, 2014 has noted resignation of Mr. Vijay Khetan, Company Secretary & Compliance Officer with effect from May 30, 2014.
    • 14 May · Board meeting

      Inter alia, to consider and approve the following items:(1). Approval of the Annual Audited Consolidated and Standalone Accounts of the Company for the year ended March 31, 2014. (2). Approval of the Audited Consolidated and Standalone financial results of the Company for the quarter and year ended March 31, 2014.(3). Recommendation of dividend on preference shares.Further, pursuant to Company's code for prevention of insider trading, the Trading window is closed from May 14, 2014 to May 27, 2014 (both days inclusive). The Trading Window shall re-open 24 hours after the financial results and intimation of dividend are submitted to the stock exchanges
  8. Apr 2014